Report Detail
Global Custom Compounded Therapy Market Growth (Status and Outlook) 2022-2028
- RnM4387709 |
- 23 February, 2022 |
- Global |
- 103 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
As the global economy mends, the 2021 growth of Custom Compounded Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Custom Compounded Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Custom Compounded Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Custom Compounded Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Custom Compounded Therapy market, reaching US$ million by the year 2028. As for the Europe Custom Compounded Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Custom Compounded Therapy players cover Fagron, Specialist Pharmacy, Nova Laboratories, and Athenex Pharma Solutions, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Custom Compounded Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Drug Customization
Meal Customization
Rehabilitation Customization
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Family
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Fagron
Specialist Pharmacy
Nova Laboratories
Athenex Pharma Solutions
ImprimisRx
Fresenius Kabi
Baxter
B. Braun
Galenic Laboratories
Pencol Compounding Pharmacy
McKesson Corporation
Clinigen Group
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Custom Compounded Therapy Market Size 2017-2028
- 2.1.2 Custom Compounded Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Custom Compounded Therapy Segment by Type
- 2.2.1 Drug Customization
- 2.2.2 Meal Customization
- 2.2.3 Rehabilitation Customization
- 2.2.4 Other
- 2.3 Custom Compounded Therapy Market Size by Type
- 2.3.1 Custom Compounded Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Custom Compounded Therapy Market Size Market Share by Type (2017-2022)
- 2.4 Custom Compounded Therapy Segment by Application
- 2.4.1 Hospital
- 2.4.2 Family
- 2.4.3 Other
- 2.5 Custom Compounded Therapy Market Size by Application
- 2.5.1 Custom Compounded Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Custom Compounded Therapy Market Size Market Share by Application (2017-2022)
3 Custom Compounded Therapy Market Size by Player
- 3.1 Custom Compounded Therapy Market Size Market Share by Players
- 3.1.1 Global Custom Compounded Therapy Revenue by Players (2020-2022)
- 3.1.2 Global Custom Compounded Therapy Revenue Market Share by Players (2020-2022)
- 3.2 Global Custom Compounded Therapy Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Custom Compounded Therapy by Regions
- 4.1 Custom Compounded Therapy Market Size by Regions (2017-2022)
- 4.2 Americas Custom Compounded Therapy Market Size Growth (2017-2022)
- 4.3 APAC Custom Compounded Therapy Market Size Growth (2017-2022)
- 4.4 Europe Custom Compounded Therapy Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Custom Compounded Therapy Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Custom Compounded Therapy Market Size by Country (2017-2022)
- 5.2 Americas Custom Compounded Therapy Market Size by Type (2017-2022)
- 5.3 Americas Custom Compounded Therapy Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Custom Compounded Therapy Market Size by Region (2017-2022)
- 6.2 APAC Custom Compounded Therapy Market Size by Type (2017-2022)
- 6.3 APAC Custom Compounded Therapy Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Custom Compounded Therapy by Country (2017-2022)
- 7.2 Europe Custom Compounded Therapy Market Size by Type (2017-2022)
- 7.3 Europe Custom Compounded Therapy Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Custom Compounded Therapy by Region (2017-2022)
- 8.2 Middle East & Africa Custom Compounded Therapy Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Custom Compounded Therapy Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Custom Compounded Therapy Market Forecast
- 10.1 Global Custom Compounded Therapy Forecast by Regions (2023-2028)
- 10.1.1 Global Custom Compounded Therapy Forecast by Regions (2023-2028)
- 10.1.2 Americas Custom Compounded Therapy Forecast
- 10.1.3 APAC Custom Compounded Therapy Forecast
- 10.1.4 Europe Custom Compounded Therapy Forecast
- 10.1.5 Middle East & Africa Custom Compounded Therapy Forecast
- 10.2 Americas Custom Compounded Therapy Forecast by Country (2023-2028)
- 10.2.1 United States Custom Compounded Therapy Market Forecast
- 10.2.2 Canada Custom Compounded Therapy Market Forecast
- 10.2.3 Mexico Custom Compounded Therapy Market Forecast
- 10.2.4 Brazil Custom Compounded Therapy Market Forecast
- 10.3 APAC Custom Compounded Therapy Forecast by Region (2023-2028)
- 10.3.1 China Custom Compounded Therapy Market Forecast
- 10.3.2 Japan Custom Compounded Therapy Market Forecast
- 10.3.3 Korea Custom Compounded Therapy Market Forecast
- 10.3.4 Southeast Asia Custom Compounded Therapy Market Forecast
- 10.3.5 India Custom Compounded Therapy Market Forecast
- 10.3.6 Australia Custom Compounded Therapy Market Forecast
- 10.4 Europe Custom Compounded Therapy Forecast by Country (2023-2028)
- 10.4.1 Germany Custom Compounded Therapy Market Forecast
- 10.4.2 France Custom Compounded Therapy Market Forecast
- 10.4.3 UK Custom Compounded Therapy Market Forecast
- 10.4.4 Italy Custom Compounded Therapy Market Forecast
- 10.4.5 Russia Custom Compounded Therapy Market Forecast
- 10.5 Middle East & Africa Custom Compounded Therapy Forecast by Region (2023-2028)
- 10.5.1 Egypt Custom Compounded Therapy Market Forecast
- 10.5.2 South Africa Custom Compounded Therapy Market Forecast
- 10.5.3 Israel Custom Compounded Therapy Market Forecast
- 10.5.4 Turkey Custom Compounded Therapy Market Forecast
- 10.5.5 GCC Countries Custom Compounded Therapy Market Forecast
- 10.6 Global Custom Compounded Therapy Forecast by Type (2023-2028)
- 10.7 Global Custom Compounded Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Fagron
- 11.1.1 Fagron Company Information
- 11.1.2 Fagron Custom Compounded Therapy Product Offered
- 11.1.3 Fagron Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Fagron Main Business Overview
- 11.1.5 Fagron Latest Developments
- 11.2 Specialist Pharmacy
- 11.2.1 Specialist Pharmacy Company Information
- 11.2.2 Specialist Pharmacy Custom Compounded Therapy Product Offered
- 11.2.3 Specialist Pharmacy Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Specialist Pharmacy Main Business Overview
- 11.2.5 Specialist Pharmacy Latest Developments
- 11.3 Nova Laboratories
- 11.3.1 Nova Laboratories Company Information
- 11.3.2 Nova Laboratories Custom Compounded Therapy Product Offered
- 11.3.3 Nova Laboratories Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Nova Laboratories Main Business Overview
- 11.3.5 Nova Laboratories Latest Developments
- 11.4 Athenex Pharma Solutions
- 11.4.1 Athenex Pharma Solutions Company Information
- 11.4.2 Athenex Pharma Solutions Custom Compounded Therapy Product Offered
- 11.4.3 Athenex Pharma Solutions Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Athenex Pharma Solutions Main Business Overview
- 11.4.5 Athenex Pharma Solutions Latest Developments
- 11.5 ImprimisRx
- 11.5.1 ImprimisRx Company Information
- 11.5.2 ImprimisRx Custom Compounded Therapy Product Offered
- 11.5.3 ImprimisRx Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 ImprimisRx Main Business Overview
- 11.5.5 ImprimisRx Latest Developments
- 11.6 Fresenius Kabi
- 11.6.1 Fresenius Kabi Company Information
- 11.6.2 Fresenius Kabi Custom Compounded Therapy Product Offered
- 11.6.3 Fresenius Kabi Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Fresenius Kabi Main Business Overview
- 11.6.5 Fresenius Kabi Latest Developments
- 11.7 Baxter
- 11.7.1 Baxter Company Information
- 11.7.2 Baxter Custom Compounded Therapy Product Offered
- 11.7.3 Baxter Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Baxter Main Business Overview
- 11.7.5 Baxter Latest Developments
- 11.8 B. Braun
- 11.8.1 B. Braun Company Information
- 11.8.2 B. Braun Custom Compounded Therapy Product Offered
- 11.8.3 B. Braun Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 B. Braun Main Business Overview
- 11.8.5 B. Braun Latest Developments
- 11.9 Galenic Laboratories
- 11.9.1 Galenic Laboratories Company Information
- 11.9.2 Galenic Laboratories Custom Compounded Therapy Product Offered
- 11.9.3 Galenic Laboratories Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Galenic Laboratories Main Business Overview
- 11.9.5 Galenic Laboratories Latest Developments
- 11.10 Pencol Compounding Pharmacy
- 11.10.1 Pencol Compounding Pharmacy Company Information
- 11.10.2 Pencol Compounding Pharmacy Custom Compounded Therapy Product Offered
- 11.10.3 Pencol Compounding Pharmacy Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Pencol Compounding Pharmacy Main Business Overview
- 11.10.5 Pencol Compounding Pharmacy Latest Developments
- 11.11 McKesson Corporation
- 11.11.1 McKesson Corporation Company Information
- 11.11.2 McKesson Corporation Custom Compounded Therapy Product Offered
- 11.11.3 McKesson Corporation Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 McKesson Corporation Main Business Overview
- 11.11.5 McKesson Corporation Latest Developments
- 11.12 Clinigen Group
- 11.12.1 Clinigen Group Company Information
- 11.12.2 Clinigen Group Custom Compounded Therapy Product Offered
- 11.12.3 Clinigen Group Custom Compounded Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Clinigen Group Main Business Overview
- 11.12.5 Clinigen Group Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Custom Compounded Therapy. Industry analysis & Market Report on Custom Compounded Therapy is a syndicated market report, published as Global Custom Compounded Therapy Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Custom Compounded Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
